Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Researchers at LegoChem Biosciences Share How Information Solutions Power Their Innovative Work

Posted on December 4th, 2018 by

With its groundbreaking work in developing antibody-drug conjugates, antibiotics, anti-coagulants and anti-cancer therapies, LegoChem Biosciences was already doing important research before joining The Hive. (more…)

Small Biotechs Progressing Beyond Startup Status

Posted on November 29th, 2018 by

When is a startup no longer a startup? Small biotech companies armed with a talented crop of scientists have been springing up all across the pharma landscape for the last several years, establishing buzzing hubs of innovation. Not all of them find their research efforts successful, but many do and then go on to be acquired by larger pharmaceutical firms that have the resources to bring their ideas to fruition. (more…)

Tackling Unmet Needs with a Proprietary Platform

Posted on November 22nd, 2018 by

Since our founding back in 2006, LegoChem Biosciences (LCB) has focused on the research and development of anti-biotic, anti-coagulant, anti-fibrosis and Antibody-Drug Conjugate (ADC) therapeutics based on our proprietary platform technology, LegoChemistry™ & Conjuall™. LCB is comprised of researchers who have varied backgrounds and R&D experiences, including the development of Factive, the first US FDA-approved drug developed in Korea. (more…)

Leveraging Partnerships to Rescue and Develop Promising Technologies

Posted on November 14th, 2018 by

There are a number of players in the field of innovative therapeutics for cancer and inflammatory disease, but our company, 4P-Pharma, is taking a somewhat different approach than most of our competition. (more…)

  1. 1
  2. 2
  3. 3
  4. 9